SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 113 filers reported holding SUNESIS PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $7,000 | -91.1% | 13,486 | -90.7% | 0.00% | – |
| Q1 2016 | $79,000 | -43.2% | 145,557 | -6.0% | 0.00% | – |
| Q4 2015 | $139,000 | +15.8% | 154,773 | +4.5% | 0.00% | – |
| Q3 2015 | $120,000 | -73.8% | 148,091 | -2.6% | 0.00% | – |
| Q2 2015 | $458,000 | -87.3% | 152,003 | -89.7% | 0.00% | -100.0% |
| Q1 2015 | $3,611,000 | +2.6% | 1,473,843 | +6.8% | 0.00% | 0.0% |
| Q4 2014 | $3,518,000 | -58.5% | 1,379,779 | +16.2% | 0.00% | -50.0% |
| Q3 2014 | $8,479,000 | +8.4% | 1,187,555 | -1.0% | 0.00% | 0.0% |
| Q2 2014 | $7,820,000 | +14.4% | 1,199,361 | +15.9% | 0.00% | 0.0% |
| Q1 2014 | $6,838,000 | +65.3% | 1,034,564 | +18.5% | 0.00% | +100.0% |
| Q4 2013 | $4,137,000 | -8.6% | 872,732 | -4.3% | 0.00% | -50.0% |
| Q3 2013 | $4,524,000 | +8.2% | 912,178 | +13.1% | 0.00% | 0.0% |
| Q2 2013 | $4,182,000 | – | 806,506 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 8,250,000 | $7,404,000 | 3.11% |
| BVF INC/IL | 4,777,381 | $4,288,000 | 0.73% |
| NEA Management Company, LLC | 7,789,644 | $7,011,000 | 0.45% |
| Palo Alto Investors LP | 6,974,854 | $6,260,000 | 0.35% |
| Healthcare Value Capital, LLC | 150,000 | $135,000 | 0.22% |
| Frontier Wealth Management LLC | 527,870 | $474,000 | 0.08% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,067,122 | $1,855,000 | 0.06% |
| Baker Brothers Advisors | 4,450,000 | $3,994,000 | 0.03% |
| Noven Financial Group, Inc. | 41,000 | $37,000 | 0.03% |
| FRANKLIN STREET ADVISORS INC /NC | 100,000 | $90,000 | 0.02% |